A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
Clinical trial NCT00001338 · COMPLETED
Trial details
- NCT number
- NCT00001338
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1993-06-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.